Literature DB >> 1642228

Assessment of amyloid beta-protein precursor gene mutations in a large set of familial and sporadic Alzheimer disease cases.

R E Tanzi1, G Vaula, D M Romano, M Mortilla, T L Huang, R G Tupler, W Wasco, B T Hyman, J L Haines, B J Jenkins.   

Abstract

A genetic locus associated with familial Alzheimer disease (FAD) and a candidate gene, APP, encoding the amyloid protein precursor have both been assigned previously to chromosome 21, and, in a few FAD families, mutations of APP have been detected. However, obligate crossovers between APP and FAD have also been reported in several FAD pedigrees, including FAD4, a large kindred showing highly suggestive evidence for linkage of the disorder to chromosome 21. In case the apparent APP crossover in FAD4 actually represented an intragenic recombination event or segregation of different mutations in different family branches, we have performed a more detailed assessment of APP as a candidate gene in this family. The entire coding region of the APP gene was sequenced for FAD4 and for FAD1, a second large kindred. No mutations were found, indicating that, in at least one chromosome 21-linked FAD pedigree, the gene defect is not accounted for by a mutation in the known coding region of the APP gene. A total of 25 well-characterized early- and late-onset FAD pedigrees were typed for genetic linkage to APP, to assess the percentage of FAD families predicted to carry mutations in the APP gene. None of the FAD families yielded positive lod scores at a recombination fraction of 0.0. To estimate the overall prevalence of FAD-associated mutations in the beta A4 domain of APP, we sequenced exons 16 and 17 in 30 (20 early- and 10 late-onset) FAD kindreds and in 11 sporadic AD cases, and we screened 56 FAD kindreds and 81 cases of sporadic AD for the presence of the originally reported FAD-associated mutation, APP717 Val----Ile (by BclI digestion). No APP gene mutations were found in any of the FAD families or sporadic-AD samples examined in this study, suggesting that the mutations in exons 16 and 17 are a rare cause of FAD. Overall, these data suggest that APP gene mutations account for a very small portion of FAD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1642228      PMCID: PMC1682666     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  35 in total

1.  Mis-sense mutation Val----Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease.

Authors:  S Naruse; S Igarashi; H Kobayashi; K Aoki; T Inuzuka; K Kaneko; T Shimizu; K Iihara; T Kojima; T Miyatake
Journal:  Lancet       Date:  1991-04-20       Impact factor: 79.321

2.  Amyloid precursor protein gene mutation in early-onset Alzheimer's disease.

Authors:  C M van Duijn; L Hendriks; M Cruts; J A Hardy; A Hofman; C Van Broeckhoven
Journal:  Lancet       Date:  1991-04-20       Impact factor: 79.321

3.  Gene mutations in inherited amyloidopathies of the nervous system.

Authors:  R E Tanzi
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

4.  Screening for the beta-amyloid precursor protein mutation (APP717: Val----Ile) in extended pedigrees with early onset Alzheimer's disease.

Authors:  M C Chartier-Harlin; F Crawford; K Hamandi; M Mullan; A Goate; J Hardy; H Backhovens; J J Martin; C V Broeckhoven
Journal:  Neurosci Lett       Date:  1991-08-05       Impact factor: 3.046

5.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.

Authors:  M C Chartier-Harlin; F Crawford; H Houlden; A Warren; D Hughes; L Fidani; A Goate; M Rossor; P Roques; J Hardy
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

6.  Alzheimer's mutation.

Authors:  G Lucotte; S Berriche; F David
Journal:  Nature       Date:  1991-06-13       Impact factor: 49.962

7.  APP717, APP693, and PRIP gene mutations are rare in Alzheimer disease.

Authors:  G D Schellenberg; L Anderson; S O'dahl; E M Wisjman; A D Sadovnick; M J Ball; E B Larson; W A Kukull; G M Martin; A D Roses
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

8.  A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease.

Authors:  J Murrell; M Farlow; B Ghetti; M D Benson
Journal:  Science       Date:  1991-10-04       Impact factor: 47.728

9.  The 717Val----Ile substitution in amyloid precursor protein is associated with familial Alzheimer's disease regardless of ethnic groups.

Authors:  K Yoshioka; T Miki; T Katsuya; T Ogihara; Y Sakaki
Journal:  Biochem Biophys Res Commun       Date:  1991-08-15       Impact factor: 3.575

10.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

View more
  51 in total

1.  Amyloid precursor protein expression modulates intestine immune phenotype.

Authors:  Kendra L Puig; Adam J Swigost; Xudong Zhou; Mary Ann Sens; Colin K Combs
Journal:  J Neuroimmune Pharmacol       Date:  2011-11-29       Impact factor: 4.147

Review 2.  Microtubule-Tau Interaction as a Therapeutic Target for Alzheimer's Disease.

Authors:  Yanina Ivashko Pachima; Liu-yao Zhou; Peng Lei; Illana Gozes
Journal:  J Mol Neurosci       Date:  2016-02       Impact factor: 3.444

Review 3.  Genetic epidemiology in aging research.

Authors:  M Daniele Fallin; Amy Matteini
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-23       Impact factor: 6.053

4.  Heller syndrome in a pre-school boy. Proposed medical evaluation and hypothesized pathogenesis.

Authors:  M Russo; R Perry; E Kolodny; C Gillberg
Journal:  Eur Child Adolesc Psychiatry       Date:  1996-09       Impact factor: 4.785

5.  Clinical rationale of genetic testing in dementia.

Authors:  G B Frisoni; M Trabucchi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-03       Impact factor: 10.154

Review 6.  The role of the amyloid protein precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration?

Authors:  D H Small
Journal:  Neurochem Res       Date:  1998-05       Impact factor: 3.996

7.  RFLP analysis for APP 717 mutations associated with Alzheimer's disease.

Authors:  S R Zeldenrust; J Murrell; M Farlow; B Ghetti; A D Roses; M D Benson
Journal:  J Med Genet       Date:  1993-06       Impact factor: 6.318

Review 8.  What can rodent models tell us about cognitive decline in Alzheimer's disease?

Authors:  Sabrina Davis; Serge Laroche
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

Review 9.  Neurogenetic diseases: molecular diagnosis and therapeutic approaches.

Authors:  U Muller; M B Graeber
Journal:  J Mol Med (Berl)       Date:  1996-02       Impact factor: 4.599

Review 10.  Genetic aspects of Alzheimer disease.

Authors:  Jennifer Williamson; Jill Goldman; Karen S Marder
Journal:  Neurologist       Date:  2009-03       Impact factor: 1.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.